A new Zofran lawsuit was filed on June 26, 2015 by the Law Offices of Harbatkin & Levasseur in The United States District Court For The District Of New Jersey under case number 2:15-CV-04536-JLL-JAD. This is one of many lawsuits that have been filed against the manufacturers of Zofran in recent months alleging that the drug caused birth defects. As previously reported on The Legal Herald, the defendants, GlaxoSmithKline have moved to consolidate federal lawsuits such as this one before one court and one judge through an MDL in Philadelphia, PA.
In this latest lawsuit, the parents of a child filed alleging that the mother took Zofran during the first trimester of her pregnancy to combat her severe morning sickness. In the complaint, the plaintiff outlined that because of prenatal exposure, her child was born with a clubbed foot where the affected feet were rotated internally at the ankle. The complaint also reported “heart throbbing” as a defect they believe was caused by ingesting Zofran.
The plaintiffs in this case filed suit in New Jersey and reside in Bergen County, New Jersey. Furthermore the complaint outlined that the plaintiff took precautions with her pregnancy such as taking prenatal vitamins 6 months prior to pregnancy. She was also a non smoker and had not ingested alcohol in 15 years. She suffered from the extreme morning sickness condition, hyperemesis gravidarum. The complaint also noted that she took 4mg of Zofran daily every 6 hours from week 5 of her pregnancy.
The complaint also outlined in detail the pain and suffering of the child as a result of the clubbed foot defect. According to the pleadings the effects of this defect will last with the child throughout his lifetime.
The federally filed complaint is one of the first where clubbed foot was the sole defect that occurred to the child.
As the Zofran litigation evolves The Legal Herald will keep you abreast of all developments.